Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Prenatal Cytomegalovirus Infection: Timing is Everything.

Pass RF.

Clin Infect Dis. 2018 Dec 31. doi: 10.1093/cid/ciy1129. [Epub ahead of print] No abstract available.

PMID:
30596970
2.

Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.

Nelson CS, Vera Cruz D, Su M, Xie G, Vandergrift N, Pass RF, Forman M, Diener-West M, Koelle K, Arav-Boger R, Permar SR.

J Virol. 2019 Feb 19;93(5). pii: e01695-18. doi: 10.1128/JVI.01695-18. Print 2019 Mar 1.

PMID:
30518646
3.

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.

Nelson CS, Huffman T, Jenks JA, Cisneros de la Rosa E, Xie G, Vandergrift N, Pass RF, Pollara J, Permar SR.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6267-6272. doi: 10.1073/pnas.1800177115. Epub 2018 Apr 30.

4.

Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention.

Pass RF, Arav-Boger R.

F1000Res. 2018 Mar 1;7:255. doi: 10.12688/f1000research.12517.1. eCollection 2018. Review.

5.

Cytomegalovirus Kinetics Following Primary Infection in Healthy Women.

Forman MS, Vaidya D, Bolorunduro O, Diener-West M, Pass RF, Arav-Boger R.

J Infect Dis. 2017 May 15;215(10):1523-1526. doi: 10.1093/infdis/jix188.

6.

Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.

Fan YH, Roy S, Mukhopadhyay R, Kapoor A, Duggal P, Wojcik GL, Pass RF, Arav-Boger R.

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7818-E7827. Epub 2016 Nov 16.

7.

Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection.

Pass RF, Anderson B.

J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1:S2-6. doi: 10.1093/jpids/piu069.

8.

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

Pass RF, Nachman S, Flynn PM, Muresan P, Fenton T, Cunningham CK, Borkowsky W, McAuley JB, Spector SA, Petzold E, Levy W, Siberry GK, Handelsman E, Utech LJ, Weinberg A; IMPAACT 1089 Team.

J Pediatric Infect Dis Soc. 2013 Dec;2(4):352-60. doi: 10.1093/jpids/pit040. Epub 2013 Jul 17.

9.

Priorities for CMV vaccine development.

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA.

Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Review.

10.

Editorial commentary: maternal laboratory assessment and fetal risk of cytomegalovirus infection.

Pass RF.

Clin Infect Dis. 2013 May;56(10):1436-7. doi: 10.1093/cid/cit065. Epub 2013 Feb 7. No abstract available.

PMID:
23392398
11.

Prevention of maternal and congenital cytomegalovirus infection.

Johnson J, Anderson B, Pass RF.

Clin Obstet Gynecol. 2012 Jun;55(2):521-30. doi: 10.1097/GRF.0b013e3182510b7b. Review.

12.

Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.

Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF.

Prev Med. 2012 May;54(5):351-7. doi: 10.1016/j.ypmed.2012.03.009. Epub 2012 Mar 21.

13.

Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine.

Arav-Boger R, Wojcik GL, Duggal P, Ingersoll RG, Beaty T, Pass RF, Yolken RH.

BMC Res Notes. 2012 Mar 13;5:140. doi: 10.1186/1756-0500-5-140.

14.

Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

Sabbaj S, Pass RF, Goepfert PA, Pichon S.

J Infect Dis. 2011 Jun 1;203(11):1534-41. doi: 10.1093/infdis/jir138.

15.

Dried blood spots and universal newborn screening for congenital cytomegalovirus infection.

Pass RF.

Clin Infect Dis. 2011 Mar 1;52(5):582-4. doi: 10.1093/cid/ciq253. No abstract available.

PMID:
21292662
16.

Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.

Murthy S, Hayward GS, Wheelan S, Forman MS, Ahn JH, Pass RF, Arav-Boger R.

PLoS One. 2011 Jan 10;6(1):e15949. doi: 10.1371/journal.pone.0015949.

17.

Congenital cytomegalovirus infection: screening and treatment.

Pass RF.

J Pediatr. 2010 Aug;157(2):179-80. doi: 10.1016/j.jpeds.2010.04.045. Epub 2010 Jun 12. No abstract available.

PMID:
20542286
18.

Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.

Hackett DJ, Zhang C, Stefanescu C, Pass RF.

Clin Vaccine Immunol. 2010 May;17(5):836-9. doi: 10.1128/CVI.00422-09. Epub 2010 Mar 10.

19.

Provocation and progress.

Pass RF.

Herpes. 2008 Nov;15(2):23. No abstract available.

PMID:
19856543
20.

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

Oliver SE, Cloud GA, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Soong SJ, Whitley RJ, Kimberlin DW; National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group.

J Clin Virol. 2009 Dec;46 Suppl 4:S22-6. doi: 10.1016/j.jcv.2009.08.012. Epub 2009 Sep 18.

21.

Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.

Pass RF.

J Clin Virol. 2009 Dec;46 Suppl 4:S73-6. doi: 10.1016/j.jcv.2009.07.002. Epub 2009 Jul 31. Review.

22.

Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection.

Rosenthal LS, Fowler KB, Boppana SB, Britt WJ, Pass RF, Schmid SD, Stagno S, Cannon MJ.

Pediatr Infect Dis J. 2009 Jun;28(6):515-20. doi: 10.1097/INF.0b013e318198c724.

23.

Vaccine prevention of maternal cytomegalovirus infection.

Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G.

N Engl J Med. 2009 Mar 19;360(12):1191-9. doi: 10.1056/NEJMoa0804749.

24.

Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States.

Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE Jr, Cannon MJ.

J Clin Virol. 2008 Nov;43(3):266-71. doi: 10.1016/j.jcv.2008.07.012. Epub 2008 Sep 7.

PMID:
18778968
25.

Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994.

Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE Jr, Cannon MJ.

Sex Transm Dis. 2008 May;35(5):472-9. doi: 10.1097/OLQ.0b013e3181644b70.

PMID:
18354346
26.

Congenital cytomegalovirus infection: impairment and immunization.

Pass RF.

J Infect Dis. 2007 Mar 15;195(6):767-9. Epub 2007 Feb 6. No abstract available.

PMID:
17299704
27.

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ.

Clin Infect Dis. 2006 Nov 1;43(9):1143-51. Epub 2006 Oct 2.

PMID:
17029132
28.

Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screening.

Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, Dobrila L, Rubinstein P, Stevens CE.

Blood. 2006 Dec 15;108(13):4275-82. Epub 2006 Aug 22.

29.
30.

Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity.

Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, Boppana SB.

J Pediatr. 2006 Mar;148(3):332-6.

PMID:
16615962
31.

Human cytomegalovirus-encoded alpha -chemokines exhibit high sequence variability in congenitally infected newborns.

Arav-Boger R, Foster CB, Zong JC, Pass RF.

J Infect Dis. 2006 Mar 15;193(6):788-91. Epub 2006 Feb 8.

PMID:
16479512
32.

Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.

Zhang C, Buchanan H, Andrews W, Evans A, Pass RF.

J Clin Virol. 2006 Mar;35(3):338-42. Epub 2006 Jan 4.

PMID:
16388984
33.

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.

Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S.

J Clin Virol. 2006 Feb;35(2):216-20. Epub 2005 Dec 20.

PMID:
16368262
34.

Congenital cytomegalovirus infection and hearing loss.

Pass RF.

Herpes. 2005 Oct;12(2):50-5. Review.

PMID:
16209862
35.

Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss.

Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ.

J Pediatr. 2005 Jun;146(6):817-23.

PMID:
15973325
36.

A key role for adolescents in the epidemiology of cytomegalovirus and genital herpes infections.

Pass RF.

Clin Infect Dis. 2004 Nov 15;39(10):1439-40. Epub 2004 Oct 25. No abstract available.

PMID:
15546078
37.
38.

HHV6 and HHV7: persistence and vertical transmission.

Pass RF.

J Pediatr. 2004 Oct;145(4):432-5. No abstract available.

PMID:
15480359
39.

Interval between births and risk of congenital cytomegalovirus infection.

Fowler KB, Stagno S, Pass RF.

Clin Infect Dis. 2004 Apr 1;38(7):1035-7. Epub 2004 Mar 15.

PMID:
15034839
40.

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong SJ, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

J Pediatr. 2003 Jul;143(1):16-25.

PMID:
12915819
41.

Of oysters and man.

Pass RF.

Herpes. 2003 May;10(1):3. No abstract available.

PMID:
12749796
42.

Maternal immunity and prevention of congenital cytomegalovirus infection.

Fowler KB, Stagno S, Pass RF.

JAMA. 2003 Feb 26;289(8):1008-11.

PMID:
12597753
43.

Diagnosis and management of cytomegalovirus infection in the newborn.

Arav-Boger R, Pass RF.

Pediatr Ann. 2002 Nov;31(11):719-25. Review. No abstract available.

PMID:
12455480
44.

Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection.

Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF.

Pediatrics. 2002 Oct;110(4):762-7.

PMID:
12359792
45.

Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease.

Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS.

J Infect Dis. 2002 Oct 15;186(8):1057-64. Epub 2002 Sep 30.

PMID:
12355354
46.

Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

Pass RF, Burke RL.

Semin Pediatr Infect Dis. 2002 Jul;13(3):196-204. Review.

PMID:
12199616
47.

Cytomegalovirus infection.

Pass RF.

Pediatr Rev. 2002 May;23(5):163-70. Review. No abstract available. Erratum in: Pediatr Rev 2002 Aug;23(8):0.

PMID:
11986492
48.

Neuropsychological functioning in patients with asymptomatic congenital cytomegalovirus infection.

Temple RO, Pass RF, Boll TJ.

J Dev Behav Pediatr. 2000 Dec;21(6):417-22.

PMID:
11132792
49.

Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus.

Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF.

J Am Acad Audiol. 2000 May;11(5):283-90.

PMID:
10821506
50.

Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.

Frey SE, Harrison C, Pass RF, Yang E, Boken D, Sekulovich RE, Percell S, Izu AE, Hirabayashi S, Burke RL, Duliège AM.

J Infect Dis. 1999 Nov;180(5):1700-3.

PMID:
10515836

Supplemental Content

Support Center